+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Eliquis"

From
Investigation Report on China's Apixaban Market 2021-2025 - Product Thumbnail Image

Investigation Report on China's Apixaban Market 2021-2025

  • Report
  • April 2021
  • 50 Pages
  • China
From
Drug Overview: Eliquis - Product Thumbnail Image

Drug Overview: Eliquis

  • Report
  • March 2018
  • 35 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Eliquis is a hematological drug used to treat and prevent blood clots. It is a direct factor Xa inhibitor, meaning it works by blocking the action of factor Xa, a protein involved in the clotting process. Eliquis is used to reduce the risk of stroke and systemic embolism in people with non-valvular atrial fibrillation, to treat deep vein thrombosis and pulmonary embolism, and to reduce the risk of recurrent deep vein thrombosis and pulmonary embolism. It is also used to prevent venous thromboembolism in people undergoing hip or knee replacement surgery. Eliquis is marketed by Bristol-Myers Squibb and Pfizer. Other companies in the market include Bayer, Daiichi Sankyo, and Boehringer Ingelheim. Show Less Read more